Condition: Residual Limb Pain · Amputation Neuroma · Phantom Limb Pain · Sponsor: Prometei Pain Rehabilitation Center
This is a double-blind randomised controlled trial (RCT) which compares the effectiveness of three surgical techniques for alleviating residual limb pain (RLP), neuroma pain and phantom limb pain (PLP). The three surgical treatments are Targeted Muscles Reinnervation (TMR), Regenerative Peripheral Nerve Interface (RPNI), and an active control (neuroma excision and muscle burying). Patients will be follow-up for 4 years.
This description comes directly from the study's public registry record.
Max Ortiz Catalan, PhD · +46708461065 · maxortizc@outlook.com
Always discuss trial participation with your own doctor first.
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Not Yet Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Michigan Health System | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Dandenong Hospital, Monash Health | Melbourne, Australia | Not Yet Recruiting |
| University of Alberta Hospital | Edmonton, Alberta, Canada | Not Yet Recruiting |
| Worker Hospital | Santiago, Chile | Not Yet Recruiting |
| Rizzoli Orthopedic Institute | Bologna, Emilia-Romagna, Italy | Recruiting |
| Sahlgrenska University Hospital | Mölndal, Västra Götaland County, Sweden | Not Yet Recruiting |
| NHS Lothian, NHS Clyde & Greater Glasgow, and NHS Grampian | Edinburgh, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05009394